AR115987A1 - ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE - Google Patents

ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Info

Publication number
AR115987A1
AR115987A1 ARP190102361A ARP190102361A AR115987A1 AR 115987 A1 AR115987 A1 AR 115987A1 AR P190102361 A ARP190102361 A AR P190102361A AR P190102361 A ARP190102361 A AR P190102361A AR 115987 A1 AR115987 A1 AR 115987A1
Authority
AR
Argentina
Prior art keywords
methods
compositions
antibodies
gdf15 antibodies
gdf15
Prior art date
Application number
ARP190102361A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR115987A1 publication Critical patent/AR115987A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente proporciona anticuerpos y fragmentos de unión al antígeno de los mismos que se unen específicamente a GDF15, así como métodos y usos de los anticuerpos.The present provides antibodies and antigen-binding fragments thereof that specifically bind GDF15, as well as methods and uses of the antibodies.

ARP190102361A 2018-08-20 2019-08-20 ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE AR115987A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862765289P 2018-08-20 2018-08-20

Publications (1)

Publication Number Publication Date
AR115987A1 true AR115987A1 (en) 2021-03-17

Family

ID=75905110

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102361A AR115987A1 (en) 2018-08-20 2019-08-20 ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Country Status (1)

Country Link
AR (1) AR115987A1 (en)

Similar Documents

Publication Publication Date Title
CO2021001893A2 (en) Anti-gdf15 antibodies, compositions and methods of use
CO2018011364A2 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
NI201800055A (en) ANTIBODIES THAT SPECIFICALLY BIND PD-1 AND ITS USES.
ECSP19026178A (en) ANTI-PD-1 ANTIBODIES AND THEIR USES
CO2020016619A2 (en) Bispecific anti-pvrig / anti-tigit antibodies and methods of use
ECSP19050049A (en) ANTI-OX40 ANTIBODIES AND THEIR USES
ECSP18005520A (en) FACTOR XI ANTIBODIES AND METHODS OF USE
ECSP18033227A (en) Agonist Antibodies That Specifically Bind Human CD40 and Methods of Use
CL2018000829A1 (en) Human anti-cd19 antibodies with high affinity
ECSP17045736A (en) COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6
CO2018002446A2 (en) Thymic stromal lymphopoietin (tslp) binding molecules and methods of using the molecules
ECSP18023386A (en) STROMAL THYMIC LYMPHOPOYETIN (TSLP) BINDING MOLECULES AND METHODS OF USE OF THE MOLECULES
CO2021002954A2 (en) Anti-αvβ8 Antibodies and Compositions and Uses Thereof
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CO2020012347A2 (en) Anti-hla-g antibodies and their uses.
CO2020012360A2 (en) Multispecific antibodies and their use
BR112016014731A2 (en) ANTI-BAFF ANTIBODIES
CO2019013718A2 (en) Anti-trkb antibodies
BR112021011124A2 (en) Anellosomes and methods of use
UY37598A (en) MIMETIC ANTIBODIES OF FGF21 AND USES OF THE SAME
AR101486A1 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA 4 AND METHODS OF USE
AR101671A1 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA-4 (ANGPTL4) AND METHODS OF USE
UY39798A (en) ANTI-CCR8 ANTIBODIES AND USES THEREOF
CL2022000052A1 (en) Pre-targeting antibodies and methods of use
BR112018010596A2 (en) antibodies to cgrp and uses thereof